Novo Nordisk Launches Once-Weekly Insulin Icodec in India, Its Seventh Global Market

Awiqli targets clinical inertia among India's 212 million+ diabetics by cutting injection burden from daily to weekly, following ONWARDS trial wins over glargine and degludec.

bt-corporate · 7/9/2026, 12:48:02 PM · Ask about this →